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Background: The overall aim of this study was to determine retinal venous pressure (RVP) in healthy chronic
smokers and compare values to those of healthy non-smokers.
Methods: Both eyes of 25 healthy chronic smokers and 41 healthy non-smokers were included. Measurements of
RVP were performed by means of contact lens ophthalmodynamometry. Ophthalmodynamometry is done by
applying increasing force on the eye via a contact lens. If a spontaneous venous pulsation was present, it was noted.
If not, the compressive force was increased until the first venous pulsation was detected, and the measurement value was
fixed and read. RVP was calculated as the sum of pressure increase induced by the instrument and intraocular pressure.
Results: Smokers had a significantly higher frequency of spontaneous venous pulsations than non-smokers (p< 0.001).
Mean values of RVP were slightly lower in smokers than in non-smokers: 15.3 and 15.5 (smokers) versus 15.9 and 16.2
(non-smokers) for the right and left eye, respectively; however, the difference in RVP between the two groups did not
reach significance. There was no significant difference in blood pressure between the two groups, but heart rate was
significantly higher in smokers (p = 0.043).
Conclusions: RVP values may differ in healthy smokers than in non-smokers. Therefore, smoking habits should be
considered when interpreting RVP results.
Keywords: Retinal venous pressure, Ophthalmodynamometric force, Smoking, Predictive preventive and personalized
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Cigarette smoking is associated with an increased risk
for vascular disease [1-3]. The positive relationship be-
tween smoking and coronary heart disease deaths in
men was first reported in 1940 [4], with the risk up until
today being strongly dose related [5]. Smoking nearly
doubles the risk of ischemic stroke [6] and more than
doubles the number of DNA breaks at a time in the
healthy persons’ circulating leukocytes [7]. Smokers are
at risk for a variety of chronic vascular diseases including
peripheral arterial disease, stroke, heart attack, abdominal
aortic aneurysm and subsequent death [8,9]. The acute
cardiovascular effects of tobacco smoking have been
attributed mainly to nicotine. Nicotine releases cate-
cholamines via stimulation of the sympathetic ganglia
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unless otherwise stated.Smoking elicits an increase in sympathoadrenergic
tone resulting in increase in the heart rate, blood pres-
sure and blood levels of catecholamines such as adren-
aline [8,12,13]. The effect of acute exposure of nicotine
on vascular resistance, however, is somewhat controver-
sial [14-16]. Some evidence suggests that vascular resist-
ance in chronic smokers may even be lower than that in
non-smokers [17].
Little is known about the hemodynamic effects of
nicotine on ocular circulation. In 1993, Rojanapongpun
and Drance found that small doses of nicotine (Nicorette
gum) increased blood flow velocities in the ophthalmic
artery of glaucoma patients whereas it significantly
decreased finger blood flow [18]. The authors, however,
did not state whether the participants were smokers or
not. In 1994, Morgado et al. [19] found a decreased
retinal blood flow in acute smokers, and 1 year later,
Williamson et al. [20] found that cigarette smoking was
associated with lower ophthalmic artery velocities. Some
years later in 1997, Kaiser and Flammer observed that inal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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velocity was higher in smokers than in non-smokers
[17]. Recently, Kalpana and colleagues observed that in
smokers, normoxic hypercapnia resulted in a significant
increase in velocity flow and total venous retinal blood
flow [21].
Retinal venous pressure (RVP) is an important param-
eter in the clinical assessment of retinal blood flow. It is
assumed that in healthy people, RVP commonly equals
the intraocular pressure (IOP); in other words, healthy
people commonly have a spontaneous venous pulsation
[22-26]. This assumption, however, is not always correct
for healthy people [22,25-27] neither for those with a
disease (e.g. glaucoma) [27-33].
Taking the above information into account, we won-
dered whether RVP in healthy chronic smokers would
be any different to healthy non-smokers. The overall aim
of this study was to measure RVP in healthy chronic
smokers (during a smoking-free period) and compare
values to healthy non-smokers.
Methods
In this cross sectional case-control study, participants
were invited by an ophthalmologist (ZV) of the Farabi
Eye Hospital in Tehran to participate in this study on a
volunteer basis and receive a routine ophthalmological
checkup in return. The study was approved by the local
ethical committee of Tehran University of Medical
Sciences, and all participants gave their consent to par-
ticipate in the study. Included were 25 smokers and 41
people who did not smoke at all. Excluded were subjects
under local or systemic medication as well as subjects
with a history of eye or general disease. None of the
participants had any pathological findings (other than in-
creased retinal venous pressure) in their routine ophthal-
mological examination. The non-contact examination
was a part of our routine ophthalmoscopic examination
of the fundus of the patients. Blood pressure examin-
ation and heart rate were measured in all participants.
RVP was measured in both eyes of all participants by
means of an ophthalmodynamometer. All measurements
were performed by the same ophthalmologist (ZV). The
interval between the last cigarette smoked and the time
of RVP measurement was 30 to 60 min.
RVP was measured in both eyes by ophthalmodyna-
mometry (IMEDOS, Jena, Germany) [34]. This device
consists of a conventional Goldmann contact lens fitted
with a pressure sensor at its outer margin where the
Goldmann contact lens is usually held during an oph-
thalmoscopic examination. The contact lens is fitted to
an outer ring by strain gauges which give an electrical
signal. This signal is linearly related to the force by
which the contact lens is attached to the eye. It is given
to the input of a central unit by a thin flexible cable.This central unit has the size of a pocket calculator. It
shows the increase of the IOP induced by the force
applied on a LCD display. The conversion from force to
pressure is based on a biophysical calibration [35,36].
Ophthalmodynamometry was conducted by applying
increasing force to the eye via the contact lens. This ap-
plied pressure can be read as a pressure increase on the
attached LCD screen based on a calibration curve. Any
small pulsatile synchronous movement of the central
retinal vein or its major branches inside the optic disc
was noted as spontaneous pulsation. In short, after pla-
cing the CLD on the eye, the ONH was brought into
sight. If a spontaneous venous pulsation was present, it
was noted. If not, the compressive force was increased
until the first venous pulsation was detected, and the
measurement value was fixed and read. RVP was calculated
as the sum of pressure increase induced by the instrument
and IOP.
Statistical analysis
Statistical analysis was performed using SPSS 16.0 soft-
ware (SPSS Inc, Chicago, Illinois, USA). Because of the
small sample size, non-parametric tests were used to
analyze the data. Comparison of quantitative variables
between smokers and non-smokers was performed using
Mann-Whitney U test. The difference in categorical data
was evaluated using chi-square test. A p value <0.05 was
considered statistically significant.
Results
The patient characteristics are listed in Table 1. The
mean number of cigarettes smoked per day by smokers
was 25 (SD 8.84) with a range of 10 to 40.
Smokers had a significantly higher frequency of spon-
taneous venous pulsations than non-smokers (86.0% vs
51%, p < 0.001). Mean values of RVP were slightly lower
in smokers than in non-smokers: 15.3 and 15.5
(smokers) versus 15.9 and 16.2 (non-smokers) for the
right and left eye, respectively; the difference in RVP,
however, between the two groups did not reach signifi-
cance (Figure 1). There was no significant difference in
blood pressure between the two groups, but heart rate
was significantly higher in smokers (p = 0.043, Table 1).
No significant differences were accounted for in the
IOP values between the smoking and non-smoking
group or between the two eyes of patients within each
group (Table 1).
Discussion
In our study, smokers had a slightly lower mean RVP
and a higher frequency of spontaneous retinal vein pulsa-
tions in comparison to age- and sex-matched healthy
non-smokers. Moreover, 49% of the non-smoking healthy
participants lacked a spontaneous venous pulsation, a
Table 1 Patient characteristics of the two groups
Variable Smokers Non-smokers p value
Number 25 41
Age, mean (SD)a 44.16 (10.65) 42.7 (13.1) n.s.
Gender (M/F) 18/7 20/21 n.s.
Systolic BP (mmHg), mean (SD)a 123.2 (21.0) 120.6 (28.7) n.s.
Diastolic BP (mmHg), mean (SD)a 71.2 (11.9) 68.9 (14.1) n.s.
Heart rate (beat/min), mean (SD)a 77.5 (7.3) 74.0 (9.3) 0.043a
IOP right eye (mmHg), mean (SD)a 14.2 (2.9) 13.0 (2.4) n.s.
IOP left eye (mmHg), mean (SD)a 14.6 (3.1) 13.1 (2.4) n.s.
M male, F female, BP blood pressure, IOP intraocular pressure, n.s. = not significant.
aIndependent Mann-Whitney U test.
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can we explain these observations?
Reports of spontaneous venous pulsations in healthy
subjects vary. Whereas some reports state that only
approximately 2% of the healthy population does not













Figure 1 Box plot of intraocular pressure (IOP) and retinal venous pre
eye, OS = left eye.the lack of a spontaneous venous pulsation in approxi-
mately 10%–24% of healthy subjects [22,25-27,37]. Our
results of 49% suggest that these values may possibly
vary from population to population, with an increased














ssure (RVP) in both eyes of smokers and non-smokers. OD = right
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pulsation in smokers go hand in hand with results of
previous studies showing a significantly higher blood
flow velocity in the majority of the ocular vessels of
smokers. Back in 1997, Kaiser and Flammer [17] dis-
cussed that the smoke of a cigarette besides many other
components contains approximately 2%–6% carbon
monoxide [38] leading to an increase in carboxyhemo-
globin levels up to 3%–15% in smokers compared to a
value of less than 1.5% in non-smokers [39]. The relative
oxygen deficit would provoke regulatory effects leading
to downstream vasodilation and an increase in blood
flow velocity. Our results support this argument; not
only was the frequency of spontaneous venous pulsations
higher in smokers but also mean values of RVP were
slightly lower in smokers compared to non-smokers.
Nevertheless, it should be noted that differences in the
methodology amongst various institutions such as the
method of ophthalmoscopy or the pulsation criterion set
by the examiner to define as spontaneous venous pulsa-
tion may lead to different results. Our definition of a
spontaneous venous pulsation was the same as that of our
colleagues Stodtmeister et al. [33].
There was no difference in systolic or diastolic blood
pressure in the two groups. These data are somewhat
paradoxical because cigarette smoking elicits an increase
in sympathoadrenergic tone, resulting in the elevation of
blood pressure [40,41]. We can only hypothesize what is
happening, yet this discrepancy may be explained as fol-
lows. Initially, a vasoconstriction mediated by nicotine
causes an increase in systolic blood pressure [42]. This
phase is followed by a decrease in blood pressure as a
consequence of depressant effects played chronically by
nicotine itself [43]. Moreover, healthy cigarette smokers
have an increased sensitivity to endogenous endothelium-
dependent and endothelium-independent vasodilators
[44]. Assuming that the increase in adrenergic tone
caused by nicotine is counteracted to some degree by
the increased sensitivity to endogenous vasodilator
stimuli, the equalization in blood pressure between the
two groups may be explained.
This study has some limitations that should be kept in
mind; the sample size is small with specific reference to
the smoking group. More studies with larger sample
sizes can help us infer more reliable assumptions about
our population. Moreover, differences in RVP between
the two groups may have reached significance had the
sample size been large enough.
Conclusion
Altogether, RVP values appear to be different in healthy
smokers than in non-smokers. Future study designs of
RVP measurements should, therefore, take into account
the differences between smokers and non-smokers.Abbreviations
RVP: Retinal venous pressure; IOP: Intraocular pressure; BP: Blood pressure.
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